Showing results (51-60 of 69) with videos related to
Sort By:
Pageof 7
Immunity|September 15, 1999
2.8 A resolution crystal structure of human TRAIL, a cytokine with selective antitumor activityS S Cha, M S Kim, Y H Choi, et al.Cancer|September 15, 1994
DNA ploidy and the percentage of cells in S-phase as prognostic factors for women with lymph node negative breast cancerT E Witzig, J N Ingle, S S Cha, et al.The Journal of Biological Chemistry|January 27, 1998
High resolution crystal structure of a human tumor necrosis factor-alpha mutant with low systemic toxicityS S Cha, J S Kim, H S Cho, et al.Gynecologic Oncology|August 1, 1995
Phase II trial of methotrexate, vinblastine, doxorubicin, and cisplatin in advanced/recurrent endometrial carcinomaH J Long, R M Langdon, S S Cha, et al.Biochemistry|November 7, 2001
Maintenance of alpha-helical structures by phenyl rings in the active-site tyrosine triad contributes to catalysis and stability of ketosteroid isomerase from Pseudomonas putida biotype BG H Nam, D S Jang, S S Cha, et al.Cancer|August 15, 1991
DNA ploidy and cell kinetic measurements as predictors of recurrence and survival in stages B2 and C colorectal adenocarcinomaT E Witzig, C L Loprinzi, N J Gonchoroff, et al.European Journal of Clinical Nutrition|January 16, 2014
Pharmacokinetics of daily versus monthly vitamin D3 supplementation in non-lactating womenM E Meekins, S S Oberhelman, B R Lee, et al.Cancer|April 1, 1996
Neuroendocrine differentiation is an independent prognostic factor in chemotherapy-treated nonsmall cell lung carcinomaJ T Schleusener, H D Tazelaar, S H Jung, et al.Biochemistry|December 31, 1997
High-resolution crystal structures of delta5-3-ketosteroid isomerase with and without a reaction intermediate analogueS W Kim, S S Cha, H S Cho, et al.Cancer|June 15, 1996
A pilot evaluation of alternating preoperative chemotherapy in the management of patients with locoregionally advanced breast carcinomaT M Pisansky, C L Loprinzi, S S Cha, et al.Pageof 7